Anna Szymanska
About Anna Szymanska
Anna Szymanska serves as the Vice President of Quality at Marker Therapeutics, Inc., a position she has held since 2020. She has extensive experience in quality control, having previously worked at Bellicum Pharmaceuticals, Inc. and Marker Therapeutics, Inc.
Current Role at Marker Therapeutics
Anna Szymanska serves as the Vice President of Quality at Marker Therapeutics, Inc. since 2020. In this role, she oversees quality assurance and compliance processes within the organization. Her leadership contributes to maintaining high standards in product development and regulatory adherence. Based in Houston, Texas, she has been instrumental in shaping quality strategies that align with the company's objectives.
Previous Experience at Marker Therapeutics
Prior to her current position, Anna Szymanska worked at Marker Therapeutics, Inc. as the Senior Director of Quality from 2019 to 2020. During her nine-month tenure, she focused on enhancing quality systems and ensuring compliance with industry regulations. This role laid the groundwork for her subsequent promotion to Vice President.
Experience at Bellicum Pharmaceuticals
Anna Szymanska held the position of Director of Quality Control at Bellicum Pharmaceuticals, Inc. from 2016 to 2019. In this role, she managed quality control processes and ensured that products met regulatory standards. Her experience in Houston, Texas, contributed to her expertise in quality management within the biopharmaceutical sector.
Educational Background in Microbiology
Anna Szymanska studied at the University of Warsaw, where she earned a Master of Science degree in Microbiology from 1992 to 1998. This academic background provided her with a strong foundation in microbiological principles and practices, which are essential in her roles within the pharmaceutical industry. Additionally, she attended Akademia Medyczna w Warszawie from 1992 to 2000, further enhancing her medical and scientific knowledge.